AmyloiDia is a biotech company founded by researchers from Karolinska Institutet and Stockholm University that builds on our invention of a method that can detect with the ultimate, single-molecule sensitivity structured peptide/protein aggregates called amyloids, and uniquely measure their concentration and size. We focus on the implementation and further advancement of this methodology for applications in healthcare, most notably for early blood-based diagnosis of amyloid diseases such as Alzheimer’s, biomedical research and industry.